REPORT ID 6179

Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Report 2017

Publish Date
25-Dec-17
Pages
112
Format
Electronic (PDF)

In this report, the global Gastrointestinal Stromal Tumor (GIST) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Gastrointestinal Stromal Tumor (GIST) Drug for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Gastrointestinal Stromal Tumor (GIST) Drug market competition by top manufacturers/players, with Gastrointestinal Stromal Tumor (GIST) Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Ariad Pharmaceuticals, Inc.
    Arog Pharmaceuticals, Inc.
    Array BioPharma Inc.
    Astex Pharmaceuticals, Inc.
    Blueprint Medicines Corporation
    Boston Biomedical, Inc.
    Calithera Biosciences, Inc.
    Chipscreen Biosciences Ltd
    Deciphera Pharmaceuticals, LLC
    F. Hoffmann-La Roche Ltd.
    Horizon Pharma Plc
    Immunicum AB
    Jiangsu Hengrui Medicine Co., Ltd.
    Kolltan Pharmaceuticals, Inc.
    Natco Pharma Limited
    Nerviano Medical Sciences S.r.l.
    Novartis AG
    Omeros Corporation
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Amcasertib
    Anagrelide hydrochloride CR
    APG-1351
    Binimetinib
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Clinic
    Hospital
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Report 2017
1 Gastrointestinal Stromal Tumor (GIST) Drug Market Overview
    1.1 Product Overview and Scope of Gastrointestinal Stromal Tumor (GIST) Drug
    1.2 Classification of Gastrointestinal Stromal Tumor (GIST) Drug by Product Category
        1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Amcasertib
        1.2.4 Anagrelide hydrochloride CR
        1.2.5 APG-1351
        1.2.6 Binimetinib
        1.2.7 Others
    1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market by Application/End Users
        1.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Market by Region
        1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2012-2022)
        1.4.3 China Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2012-2022)
        1.4.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2012-2022)
        1.4.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2012-2022)
        1.4.7 India Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Gastrointestinal Stromal Tumor (GIST) Drug (2012-2022)
        1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2012-2022)
        1.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2012-2022)

2 Global Gastrointestinal Stromal Tumor (GIST) Drug Competition by Players/Suppliers, Type and Application
     2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Competition by Players/Suppliers
        2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug (Volume and Value) by Type
        2.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Type (2012-2017)
        2.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Type (2012-2017)
    2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug (Volume and Value) by Region
        2.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Region (2012-2017)
        2.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Region (2012-2017)
    2.4 Global Gastrointestinal Stromal Tumor (GIST) Drug (Volume) by Application

3 United States Gastrointestinal Stromal Tumor (GIST) Drug (Volume, Value and Sales Price)
    3.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales and Value (2012-2017)
        3.1.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2012-2017)
        3.1.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2012-2017)
        3.1.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Trend (2012-2017)
    3.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Players
    3.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Type
    3.4 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Application

4 China Gastrointestinal Stromal Tumor (GIST) Drug (Volume, Value and Sales Price)
    4.1 China Gastrointestinal Stromal Tumor (GIST) Drug Sales and Value (2012-2017)
        4.1.1 China Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2012-2017)
        4.1.2 China Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2012-2017)
        4.1.3 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Trend (2012-2017)
    4.2 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Players
    4.3 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Type
    4.4 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Application

5 Europe Gastrointestinal Stromal Tumor (GIST) Drug (Volume, Value and Sales Price)
    5.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales and Value (2012-2017)
        5.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2012-2017)
        5.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Trend (2012-2017)
    5.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Players
    5.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Type
    5.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Application

6 Japan Gastrointestinal Stromal Tumor (GIST) Drug (Volume, Value and Sales Price)
    6.1 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales and Value (2012-2017)
        6.1.1 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2012-2017)
        6.1.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Trend (2012-2017)
    6.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Players
    6.3 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Type
    6.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Application

7 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug (Volume, Value and Sales Price)
    7.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Value (2012-2017)
        7.1.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Trend (2012-2017)
    7.2 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Players
    7.3 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Type
    7.4 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Application

8 India Gastrointestinal Stromal Tumor (GIST) Drug (Volume, Value and Sales Price)
    8.1 India Gastrointestinal Stromal Tumor (GIST) Drug Sales and Value (2012-2017)
        8.1.1 India Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2012-2017)
        8.1.2 India Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2012-2017)
        8.1.3 India Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Trend (2012-2017)
    8.2 India Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Players
    8.3 India Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Type
    8.4 India Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share by Application

9 Global Gastrointestinal Stromal Tumor (GIST) Drug Players/Suppliers Profiles and Sales Data
    9.1 Ariad Pharmaceuticals, Inc.
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Arog Pharmaceuticals, Inc.
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Array BioPharma Inc.
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Astex Pharmaceuticals, Inc.
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Blueprint Medicines Corporation
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Boston Biomedical, Inc.
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Calithera Biosciences, Inc.
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Chipscreen Biosciences Ltd
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Deciphera Pharmaceuticals, LLC
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 F. Hoffmann-La Roche Ltd.
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Horizon Pharma Plc
    9.12 Immunicum AB
    9.13 Jiangsu Hengrui Medicine Co., Ltd.
    9.14 Kolltan Pharmaceuticals, Inc.
    9.15 Natco Pharma Limited
    9.16 Nerviano Medical Sciences S.r.l.
    9.17 Novartis AG
    9.18 Omeros Corporation

10 Gastrointestinal Stromal Tumor (GIST) Drug Maufacturing Cost Analysis
    10.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
    10.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2017-2022)
    14.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate Forecast (2017-2022)
       14.1.3